NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa.
| Revenue (Most Recent Fiscal Year) | $8.69M |
| Net Income (Most Recent Fiscal Year) | $-3.28M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.74 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.19 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -31.64% |
| Net Margin (Trailing 12 Months) | -30.80% |
| Return on Equity (Trailing 12 Months) | -54.95% |
| Return on Assets (Trailing 12 Months) | -27.84% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.88 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.15 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.15 |
| Inventory Turnover (Trailing 12 Months) | 3.78 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.90 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.45 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 7.65M |
| Free Float | 6.08M |
| Market Capitalization | $17.76M |
| Average Volume (Last 20 Days) | 0.05M |
| Beta (Past 60 Months) | 0.52 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.55% |
| Percentage Held By Institutions (Latest 13F Reports) | 2.21% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |